alkannin has been researched along with Benign Neoplasms in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Valipour, M | 1 |
| Cui, JH; Ding, J; Li, SS; Meng, QQ; Song, HL; Wang, RB; Xu, Y; Yang, K; Zhang, X; Zhou, W | 1 |
| Cui, JH; Li, SS; Meng, QQ; Xiao, S; Zhang, X; Zhou, W | 1 |
| Chen, J; Hu, X; Jiang, Z; Wang, B; Wang, Y; Xie, J | 1 |
2 review(s) available for alkannin and Benign Neoplasms
| Article | Year |
|---|---|
Recent advances of antitumor shikonin/alkannin derivatives: A comprehensive overview focusing on structural classification, synthetic approaches, and mechanisms of action.
Topics: Antineoplastic Agents; Apoptosis; Humans; Naphthoquinones; Neoplasms | 2022 |
Advance in Anti-tumor Mechanisms of Shikonin, Alkannin and their Derivatives.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Cell Death; Drug Screening Assays, Antitumor; Humans; Lithospermum; Naphthoquinones; Neoplasms; Reactive Oxygen Species | 2018 |
2 other study(ies) available for alkannin and Benign Neoplasms
| Article | Year |
|---|---|
Design, synthesis, and biological evaluation of shikonin and alkannin derivatives as potential anticancer agents via a prodrug approach.
Topics: Alkylation; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Drug Design; Female; Male; Mice; Microsomes, Liver; Naphthoquinones; Neoplasms; Prodrugs; Rats; Reactive Oxygen Species; Stereoisomerism; Structure-Activity Relationship; Transplantation, Heterologous; Transplantation, Homologous | 2014 |
Shikonin and its analogs inhibit cancer cell glycolysis by targeting tumor pyruvate kinase-M2.
Topics: Antineoplastic Agents; Cell Line, Tumor; Enzyme Inhibitors; Glucose; Glycolysis; Humans; Lactic Acid; Naphthoquinones; Neoplasms; Pyruvate Kinase | 2011 |